# EDGAR Filing Document

**Accession Number:** 0001086888
**File Stem:** 0001086888-23-000019
**Filing Date:** 2023-3
**Character Count:** 6191
**Document Hash:** ac14abe7d4bd6c9b68078a00febd1014
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001086888-23-000019.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001086888-23-000019

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20230307

**FILED AS OF DATE**: 20230307

**DATE AS OF CHANGE**: 20230307

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MANULIFE FINANCIAL CORP
- **CENTRAL INDEX KEY:** 0001086888
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **IRS NUMBER:** 889897526
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14942
- **FILM NUMBER:** 23712797

**BUSINESS ADDRESS:**
- **STREET 1:** 200 BLOOR ST EAST, NT-10
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M4W1E5
- **BUSINESS PHONE:** 416-926-3000

**MAIL ADDRESS:**
- **STREET 1:** 200 BLOOR ST EAST, NT-10
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M4W1E5

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### Form 6-K

### <br>

#### REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13 a -16 OR 15d -16 UNDER THE

#### SECURITIES EXCHANGE ACT OF 1934

#### <br>
For the month of <u>March, 2023</u>

Commission File Number: 1-14942

### MANULIFE FINANCIAL CORPORATION
(Translation of registrant's name into English)

#### 200 Bloor Street East

#### North Tower 10

#### Toronto, Ontario, Canada M4W 1E5
(416) 926-3000

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☑

------

#### DOCUMENTS FILED AS PART OF THIS FORM 6-K
The following documents, filed as exhibits to this Form 6-K, are incorporated by reference as part of this Form 6-K:

---

| | |
|:---|:---|
| Exhibit | Description of Exhibit |
| 99.1 | News release dated March 7, 2023 announcing subordinated debenture issue.<br>|

---

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | MANULIFE FINANCIAL CORPORATION |
|  | By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; */s/ Scott MacIntosch* |
|  | Name:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Scott MacIntosh |
|  | Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Assistant Corporate Secretary<br>|
| Date: March 7, 2023<br>|  |

---

## Exhibit 99.1

![](image0.jpg)

## News<br> Release
C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945<br> For Immediate Release<br> March 7, 2023

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br> Manulife announces Subordinated Debenture issue
**TORONTO** - Manulife Financial Corporation ("**MFC**") announced today that it intends to issue $1.2 billion principal amount of 5.409% fixed/floating subordinated debentures due March 10, 2033 (the "**Debentures**"). MFC intends to file a prospectus supplement to its existing base shelf prospectus in respect of this issue.

The Debentures will bear interest at a fixed rate of 5.409% until March 10, 2028 and thereafter at a rate of 1.85% over Daily Compounded CORRA. The Debentures mature on March 10, 2033.

Subject to prior regulatory approval, MFC may redeem the Debentures, in whole or in part, on or after March 10, 2028 at a redemption price equal to par, together with accrued and unpaid interest to, but excluding, the date fixed for redemption. The Debentures will constitute subordinated indebtedness, ranking equally and rateably with all other subordinated indebtedness of MFC from time to time issued and outstanding (other than subordinated indebtedness which has been further subordinated in accordance with its terms).

The offering is being done on a best efforts agency basis by a syndicate co-led by RBC Capital Markets, Scotiabank and TD Securities. The offering is expected to close on March 10, 2023.

MFC intends to use the net proceeds from the offering of the Debentures for general corporate purposes, including investment in subsidiaries and potential future redemptions of existing securities.

The Debentures have not been and will not be registered in the United States under the United States Securities Act of 1933, as amended (the "**Securities Act**"), or the securities laws of any state of the United States and may not be offered, sold or delivered, directly or indirectly, in the United States or to, or for the account or benefit of, a "U.S. person" (as defined in Regulation S under the Securities Act) absent registration or an applicable exemption from such registration requirements. This press release does not constitute an offer to sell or a solicitation to buy securities in the United States and any public offering of the securities in the United States must be made by means of a prospectus.

#### About Manulife
Manulife Financial Corporation is a leading international financial services provider, helping people make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we provide financial advice and insurance, operating as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States. Through Manulife Investment Management, the global brand for our Global Wealth and Asset Management segment, we serve individuals, institutions, and retirement plan members worldwide. At the end of 2022, we had more than 40,000 employees, over 116,000 agents, and thousands of distribution partners, serving over 34 million customers. We trade as 'MFC' on the Toronto, New York, and the Philippine stock exchanges and under '945' in Hong Kong.<br>

Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; **Media Contact**<br>Cheryl Holmes<br> Manulife<br> 416-557-0945<br> <u>cheryl_holmes@manulife.com</u><br>| &nbsp;&nbsp;&nbsp;&nbsp; **Investor Relations**<br>Hung Ko<br> Manulife<br> 416-852-4875<br> <u>hung_ko@manulife.com</u><br>|

---